As Vice President, Strategic Development, Dr. Pritchard is responsible for global growth strategy for Celerion. In addition, he works with strategic clients to engage Celerion’s global team of drug development and regulatory affairs experts to bring drug products efficiently through early clinical testing. Fred was trained in life sciences and pharmacology (B.Sc (Hons), M.Sc., Queen’s University, Canada) and clinical pharmacology (Ph.D., The Pennsylvania State University College of Medicine).